DRW Securities’s Sunshine Biopharma SBFM Stock Holding History

DRW Securities’s Portfolio SBFM Stock Details SBFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-4,498	Closed	-$67K	–	1634
2025 Q3	$67K	Buy	+4,498	New	+$66.7K	﹤0.01%	1215

Other funds holding SBFM

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SAG

SageView Advisory Group Newport Beach, California $3.05B AUM 18.61% 1-Year Est. Return

DRW Securities's SBFM Position: Q4 2025 in Review

DRW Securities sold out of Sunshine Biopharma (SBFM) in Q4 2025, closing a stake of 4,498 shares — an estimated $67K sold.

DRW Securities first reported a position in SBFM in Q3 2025 and held it in 1 quarter. The position peaked at $67K in Q3 2025. 9 funds tracked by Wall St. Rank hold SBFM as of Q4 2025.

DRW Securities reported no remaining Sunshine Biopharma position as of Q4 2025 after selling out during the quarter.
DRW Securities sold 4,498 Sunshine Biopharma shares in Q4 2025, an estimated $67K.
DRW Securities first reported a position in Sunshine Biopharma in Q3 2025 and held it in 1 quarter.
DRW Securities's Sunshine Biopharma position peaked at $67K in Q3 2025.
9 funds tracked by Wall St. Rank held Sunshine Biopharma as of Q4 2025.

Based on DRW Securities's 13F filing for Q4 2025, filed 12 Feb 2026.